Salmeterol increase risk of death in asthma patients?
沙美特罗会提高哮喘病人的死亡可能性？
Results: Salmeterol and fluticasone propionate powder marked improvement in asthma symptoms.
结果：沙美特罗替卡松粉剂明显改善哮喘病状。
Objective To evaluate the clinical effect of inhaling salmeterol-fluticasone on patients with COPD.
目的探讨吸入沙美特罗-替卡松粉治疗慢性阻塞性肺疾病（COPD）的疗效。
Conclusion Salmeterol and fluticasone propionate inhalant can improve pulmonary function in COPD patients.
结论沙美特罗替卡松干粉吸入能够改善慢性阻塞性肺疾病的肺功能。
Conclusion: The onset time and level of asthma can be decreased with proper dosage and inhalation method of Salmeterol fluticasone propionate.
结论：沙美特罗替卡松治疗哮喘，只要用量恰当，吸入的方法正确，可以减少哮喘发作的次数和减轻哮喘发作的程度。
Conclusion the inhalation of salmeterol for COPD can significantly improve lung function, alleviate clinic symptoms and improve life quality of the patients.
结论对COPD患者给予沙美特罗吸入治疗能明显改善患者肺功能，缓解临床症状和提高生活质量。
Compared with regular salbutamol, regular salmeterol was not associated with a significant increase in fatal or nonfatal serious adverse events in patients not taking inhaled corticosteroids.
对不吸入糖皮质激素的患者来说，规律使用沙美特罗与规律使用沙丁胺醇相比，其致死性及非致死性严重不良事件的发生率并无显著增加。
Clinical implications of this review are that for patients with asthma that is poorly controlled with moderate doses of inhaled corticosteroids, additional salmeterol can give symptomatic benefit.
该综述与临床的联系在于：对于使用中等剂量吸入激素控制效果欠佳的哮喘患者，加用沙美特罗有助于症状的改善。
Clinical implications of this review are that for patients with asthma that is poorly controlled with moderate doses of inhaled corticosteroids, additional salmeterol can give symptomatic benefit.
该综述与临床的联系在于：对于使用中等剂量吸入激素控制效果欠佳的哮喘患者，加用沙美特罗有助于症状的改善。
应用推荐